Sonic Healthcare Limited's Preliminary Final Report for the financial year ending June 30, 2026, disclosed a 12.7% increase in revenue to AUD 10,867 million and an 18.4% rise in net profit to AUD 608 million. The company maintained its final dividend at 63 cents per share and reported an 11% increase in EBITDA before non-recurring items to AUD 1,933 million. This growth was driven by a 5% organic revenue increase and successful synergy capture from acquisitions in Switzerland and Germany. Challenges included a non-cash adjustment due to a cyber event affecting US operations. Sonic Healthcare undertook strategic acquisitions and reported a net cash inflow from operating activities of AUD 1,405 million, operating under a going concern basis despite a working capital shortfall.
Key Points
Sonic Healthcare Limited reported a revenue increase of 12.7% to AUD 10,867 million for the financial year ended 30 June 2026.
The net profit attributable to Sonic shareholders was AUD 608 million, an 18.4% increase from the previous year.
The final dividend for the year was maintained at 63 cents per share, with a higher franked amount per security compared to the previous year.
The EBITDA before non-recurring items increased by 11% to AUD 1,933 million.
Sonic Healthcare experienced strong revenue and EBITDA growth, with organic revenue growth of 5%.
The company has been successful in capturing synergies from acquisitions in Switzerland and Germany.
A non-cash adjustment related to a cyber event with Change Healthcare affected the US operations.
Sonic Healthcare issued shares as part of consideration for the acquisition of Laboratory Group Dr. Kramer & Colleagues.
Net cash inflow from operating activities was AUD 1,405 million.
The company's financial statements were prepared on a going concern basis despite a working capital deficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.